For investigations targeting the limits of pharmacological weight loss, Retatrutide represents the current frontier
Where the research is strongest: tendon and ligament healing, gut and intestinal repair, nerve regeneration, post-surgical recovery, and reduction of NSAID-induced gastric damage
Tirzepatide Once Weekly for the Treatment of Obesity in People Without Diabetes (SURMOUNT-1) New England Journal of Medicine In 2,539 adults with BMI 30, tirzepatide 15 mg produced 22.5% mean body weight loss at 72 weeks the largest weight reduction ever achieved with a pharmaceutical agent at the time
The increasing prevalence of obesity-related comorbidities such as diabetes, cardiovascular diseases, and hypertension has escalated the demand for more potent and targeted therapies, roles best fulfilled by prescription drugs
Network pharmacology and transcriptomics to explore the pharmacological mechanisms of 20(S)-protopanaxatriol in the treatment of depression
Weight care platforms that combine FDA-approved medications with personalized support offer a safer alternative to navigating compounded options on your own